MannKind Corp. (MNKD)

5.93 -0.06 (-1.00%) USD  |  NASDAQ  |  Dec 23, 16:00
5.94 +0.01 (+0.17%) Pre-Market: 20:00
More

MannKind SG&A Expense (TTM): 195.42M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for MNKD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Moderna, Inc. 1.061B
Vertex Pharmaceuticals, Inc. 1.644B
Ocugen, Inc. 27.76M
Protagonist Therapeutics, Inc. 42.37M
Ovid Therapeutics, Inc. 22.56M